Prevalence of Deficiency of Vitamin D in Critically Ill Patients
Investigating the Prevalence of Deficiency of Vitamin D in Critically Ill Patients and Its Effects on the Prognosis
1 other identifier
observational
662
1 country
1
Brief Summary
Vitamin D has been shown to related to clinical outcomes in critically ill patients. The object of this study is to investigate the prevalence of Vitamin D deficiency in critically ill patients with various length of ICU stay .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2018
CompletedFirst Posted
Study publicly available on registry
August 21, 2018
CompletedStudy Start
First participant enrolled
August 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedApril 22, 2021
April 1, 2021
1.9 years
August 14, 2018
April 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The prevalence of Vitamin D deficiency
Investigate the prevalence of vitamin D deficiency among groups
1 day at enrollment
Secondary Outcomes (5)
Difference of mortality on 28th and 90th day in group 2
90 days
Difference of mortality on 28th and 90th day in group 3, 4, and 5
90 days
Serial changes of serum vitamin D levels in group 2
28 days
Difference of 28-day ventialtor-free days
28 days
Difference of 28-day ICU-free days
28 days
Study Arms (5)
Group 1
Patients admitted to ICU less than 48 hours and the anticipated stay is less than 5 days. Take blood sample on the day of enrollment.
Group 2
Patients admitted to ICU less than 48 hours and the anticipated stay is longer than 5 days. Take blood sample on the day of enrollment, 7th, 14th, 21st, and 28th. Stop blood sample once exit.
Group 3
Patients admitted to ICU 3\~7 days. Take blood sample on the day of enrollment.
Group 4
Patients admitted to ICU 8\~14 days. Take blood sample on the day of enrollment.
Group 5
Patients admitted to ICU 15\~28 days. Take blood sample on the day of enrollment.
Eligibility Criteria
This is a multi-center, cross-sectional study involving four medical center in Taipei, Taiwan, which are National Taiwan University Hospital (NTUH), Far Eastern Memorial Hospital (FEMH), MacKay Memorial Hospital (MMH), and Taipei Medical University Hospital (TMUH). The target population is all the ICU patients, divided into four groups according to the length of ICU stay. The serum level of vit D, ICU event such as infection, ventilator dependency is to be recorded.
You may qualify if:
- All ICU patients
You may not qualify if:
- , Less than 20 years 2, BMI \< 18 kg/m\^2 3, Had large dose vit D within previous four weeks (over 3000 IU per day) 4, ICU admission within previous three months 5, Have disease affecting vit D level, calcium metabolism, bone metabolism such as parathyroid disease, Rickets, liver cirrhosis child C 6, Communication difficulty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Related Publications (1)
Kuo YT, Kuo LK, Chen CW, Yuan KC, Fu CH, Chiu CT, Yeh YC, Liu JH, Shih MC. Score-based prediction model for severe vitamin D deficiency in patients with critical illness: development and validation. Crit Care. 2022 Dec 21;26(1):394. doi: 10.1186/s13054-022-04274-9.
PMID: 36544226DERIVED
Biospecimen
blood sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chung-Wei Chen, MD
Far Eastern Memorial Hospital
- PRINCIPAL INVESTIGATOR
Li-Kuo Kuo, MD
Mackay Memorial Hospital
- PRINCIPAL INVESTIGATOR
Kuo-Ching Yuan, MD
Taipei Medical University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2018
First Posted
August 21, 2018
Study Start
August 23, 2018
Primary Completion
July 30, 2020
Study Completion
November 30, 2020
Last Updated
April 22, 2021
Record last verified: 2021-04